Helen of Troy Ltd

HELE remains in a Stage 2 advancing regime with rising intermediate support, but long-term downtrend persists. Price has pulled back into the 50 SMA zone and is holding support, yet short-term momentum is mixed and failure to reclaim the 9/21 EMAs suggests patience. Execution is best deferred into clearer pullbacks or a confirmed re-engagement above short-term EMAs.

• ↑Q1 fiscal 2027 sales hit $402.1M (+8.2% YoY); outlook upgraded.
• ↑Strong book-to-price ratio (3.3x) and high earnings yield underpin valuation.
• ↓Gross margin slipped to 46% (-110bps YoY), pressuring earnings.